Conmed Corp reports results for the quarter ended March 31 - Earnings Summary

Conmed

30/04/2025 22:51

Conmed Corp CNMD.N reported quarterly adjusted earnings of 95 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of 79 cents.  The mean expectation of seven analysts for the quarter was for earnings of 81 cents per share. Wall Street expected results to range from 80 cents to 83 cents per share.

Revenue rose 2.9% to $321.26 million from a year ago; analysts expected $313.37 million.

Conmed Corp's reported EPS for the quarter was 19 cents​.

The company reported quarterly net income of $6.04 million.

Conmed Corp shares had fallen by 15.3% this quarter and lost 25.2% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 19% in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "hold"

Wall Street's median 12-month price target for Conmed Corp is $77.50

This summary was machine generated from LSEG data April 30 at 09:51 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Mar. 31 2025
0.81
0.95
Beat
Dec. 31 2024
1.20
1.34
Beat
Sep. 30 2024
0.99
1.05
Beat
Jun. 30 2024
0.91
0.98
Beat